Cargando…
Nanoprodrugs of NSAIDs: Preparation and Characterization of Flufenamic Acid Nanoprodrugs
We demonstrated that hydrophobic derivatives of the nonsteroidal anti-inflammatory drug (NSAID)flufenamic acid (FA), can be formed into stable nanometer-sized prodrugs (nanoprodrugs) that inhibit the growth of glioma cells, suggesting their potential application as anticancer agent. We synthesized h...
Autores principales: | Lee, Bong-Seop, Yoon, Chi Woo, Osipov, Arsen, Moghavem, Nuriel, Nwachokor, Daniel, Amatya, Rina, Na, Rebekah, Pantoja, Joe L., Pham, Michael D., Black, Keith L., Yu, John S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3095474/ https://www.ncbi.nlm.nih.gov/pubmed/21603162 http://dx.doi.org/10.1155/2011/980720 |
Ejemplares similares
-
Hydrophilic Fluorescent Nanoprodrug of Paclitaxel
for Glioblastoma Chemotherapy
por: Daniel, Jonathan, et al.
Publicado: (2019) -
Indocyanine green potentiated paclitaxel nanoprodrugs for imaging and chemotherapy
por: Xiang, Xiujuan, et al.
Publicado: (2022) -
Reactive Oxygen Species-Activated Nanoprodrug of Ibuprofen for Targeting Traumatic Brain Injury in Mice
por: Clond, Morgan A., et al.
Publicado: (2013) -
A redox-responsive dihydroartemisinin dimeric nanoprodrug for enhanced antitumor activity
por: Li, Yawei, et al.
Publicado: (2021) -
An erythrocyte-delivered photoactivatable oxaliplatin nanoprodrug for enhanced antitumor efficacy and immune response
por: Wang, Na, et al.
Publicado: (2021)